Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu.
about
P1343
GREB1 functions as a growth promoter and is modulated by IL6/STAT3 in breast cancerp27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptorH3K27 demethylation by JMJD3 at a poised enhancer of anti-apoptotic gene BCL2 determines ERα ligand dependencyCdc25B functions as a novel coactivator for the steroid receptorsRegulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifenThe origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer.Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma modelEndocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancerMechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome ItPhosphatidylinositol 3-kinase and antiestrogen resistance in breast cancerTargeting of erbB3 receptor to overcome resistance in cancer treatmentCooperating transcription factors mediate the function of estrogen receptorFrom bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?Lycium barbarum inhibits growth of estrogen receptor positive human breast cancer cells by favorably altering estradiol metabolismOptimized digital counting colonies of clonogenic assays using ImageJ software and customized macros: comparison with manual countingHeregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinaseAn Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor XenograftsCancer cells resistant to therapy promote cell surface relocalization of GRP78 which complexes with PI3K and enhances PI(3,4,5)P3 productionEffects of Ginkgo biloba on chemically-induced mammary tumors in rats receiving tamoxifenHuman epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program.MIDClass: microarray data classification by association rules and gene expression intervals.Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycinEnhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancerOlive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin) in HER2-overexpressing breast cancer cells.Genomics of signaling crosstalk of estrogen receptor alpha in breast cancer cells.Cardio-oncology in targeting the HER receptor family: the puzzle of different cardiotoxicities of HER2 inhibitors.tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO)Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies.c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.HER-2/neu as a predictive marker of response to breast cancer therapy.Breast cancer and amyloid bodies: is there a role for amyloidosis in cancer-cell dormancy?Minireview: Tipping the balance: ligand-independent activation of steroid receptors.Artemin, a member of the glial cell line-derived neurotrophic factor family of ligands, is HER2-regulated and mediates acquired trastuzumab resistance by promoting cancer stem cell-like behavior in mammary carcinoma cells.Enhanced resistance to tamoxifen by the c-ABL proto-oncogene in breast cancer.Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials.EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer.Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy.Role of HER2 gene overexpression in breast carcinoma.GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells
P2860
Q21560759-8F3B3647-D5E2-4BA6-87B4-AA2B118AF90EQ24294568-BA564286-92DD-44DE-9E09-5521030FD5B6Q24297204-55E2A6D6-C1E8-488D-914E-1545725CE440Q24322697-1E7DC20D-D1C7-4FC8-9B4A-026C3DD38ACDQ24548253-3FCED1D1-9D72-40DD-BF9A-EB4B79810AE3Q24632895-660D26D5-AD08-406E-AAD9-5F8D67BA66F0Q24796156-CB4EB0AB-684F-4033-AE40-FB9275314ED4Q24805875-3BD80259-815B-4D61-B25F-7250341C0317Q24813627-3D9A6359-598D-4B3D-B612-288960D50B4BQ26752780-0CDBA0C7-6649-4A41-A7AC-BA2131033454Q26862550-FE4E7433-D250-4890-9CF2-C30D9BDDA3CFQ26864668-4D0933D7-33F1-460D-B215-238D4F52C82BQ26996464-04299AC7-2212-4361-B043-C70B13E8CB17Q28084982-2CB9AD46-0648-45C0-8836-F31AEA55F707Q28241653-F75003D5-48B9-48EA-908E-200B0CC0BA99Q28247888-A0207CBD-24E2-4FCC-B6AF-39FD7878F981Q28285513-67CAB37C-E20A-4908-9C00-43A629363671Q28468447-CCD907CB-2E96-4191-9258-AA2C7933AA9AQ28534981-154136BF-F127-4760-AAA4-A2D5A3420DABQ28703563-F7810CD4-8ED3-4CFC-A564-E8D7892372CAQ30437453-19C9ED15-E94C-4D97-9F5E-586C056FC7A2Q30660977-DF074A62-7A97-423D-B34C-DD9EFD520314Q30839490-F225DEB4-EC72-4059-85F7-570600EAC4EEQ33281087-49DC8C1D-9E23-44A6-BA78-7AF8FE7F08AAQ33284158-CFC816AD-DE99-4335-8B92-ACFAF1806AD6Q33325484-8DE35674-9EE8-4AD4-B41B-278890922C82Q33352155-C3AB5872-19BD-4840-A018-3BE91109EF0EQ33394374-F56B802E-F420-41AA-92D6-31EE5C815446Q33519052-B9563C3B-71C2-40CC-975F-E59B30176574Q33538427-FA807704-87AF-4BBA-860D-5E67286992ABQ33538428-31FE77A6-5026-4DA4-9365-B629B4329404Q33627645-1375AA8E-5DAE-46D4-A7E7-1CDB9DED3A54Q33631775-53301C35-7D62-45C5-AD9C-654658F41C12Q33718457-216DF89A-943F-4671-A497-A72E7D2FB24AQ33727026-819A8F23-0513-42B5-9AE8-BDE18A0D91E5Q33735001-A263BC19-0593-4410-9D29-482701C1B995Q33793142-ABDD616E-883F-4508-B0D1-419380B1AEF5Q33801908-A65099D4-82A0-4358-94E1-E1E185B0A957Q33810080-45F63E55-5874-4E82-94B2-4CFA3A525B41Q33928138-F870B609-633A-4E06-ABB0-543BCD3A92F9
P2860
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Estrogen-dependent, tamoxifen- ...... lls transfected with HER2/neu.
@en
Estrogen-dependent, tamoxifen- ...... lls transfected with HER2/neu.
@nl
type
label
Estrogen-dependent, tamoxifen- ...... lls transfected with HER2/neu.
@en
Estrogen-dependent, tamoxifen- ...... lls transfected with HER2/neu.
@nl
prefLabel
Estrogen-dependent, tamoxifen- ...... lls transfected with HER2/neu.
@en
Estrogen-dependent, tamoxifen- ...... lls transfected with HER2/neu.
@nl
P2093
P2860
P356
P1476
Estrogen-dependent, tamoxifen- ...... lls transfected with HER2/neu.
@en
P2093
C K Osborne
D Tripathy
E Coronado
H M Shepard
R M Johnson
P2860
P2888
P356
10.1007/BF01961241
P407
P4510
P577
1992-01-01T00:00:00Z
P6179
1002229729